Jump to content

Pages with the fewest revisions

Pharmacopedia
BrowseCategoriesLog in

Showing below up to 50 results in range #251 to #300.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Mupirocin (2 revisions)
  2. Effect:Existential self-realization (2 revisions)
  3. Problem:MASH with stage 2-3 fibrosis (2 revisions)
  4. Insulin Glargine (2 revisions)
  5. Effect:Pattern recognition suppression (2 revisions)
  6. Effect:Headache (2 revisions)
  7. Western licorice (2 revisions)
  8. Effect:Muscle cramps (2 revisions)
  9. Effect:Alertness (2 revisions)
  10. Phentermine (2 revisions)
  11. Effect:Autonomous voice communication (2 revisions)
  12. Effect:Dehydration (2 revisions)
  13. Phenotype:CYP3A4 intermediate metabolizer (2 revisions)
  14. Solifenacin (2 revisions)
  15. Effect:Double vision (2 revisions)
  16. Phenotype:CYP2C19 poor metabolizer (2 revisions)
  17. Meloxicam (2 revisions)
  18. Effect:Memory replays (2 revisions)
  19. Problem:Fibromyalgia (2 revisions)
  20. Effect:Agranulocytosis (2 revisions)
  21. Problem:Tourette Syndrome (2 revisions)
  22. Ivermectin (2 revisions)
  23. Effect:Color enhancement (2 revisions)
  24. Problem:Rheumatoid Arthritis (2 revisions)
  25. Effect:Growth suppression (2 revisions)
  26. Problem:Autism Spectrum Disorder (2 revisions)
  27. Ketoconazole (2 revisions)
  28. Effect:Tactile suppression (2 revisions)
  29. Problem:Seasonal Affective Disorder (2 revisions)
  30. Effect:Visual disconnection (2 revisions)
  31. Problem:Dissociative Identity Disorder (2 revisions)
  32. Sodium Bicarbonate (2 revisions)
  33. Effect:Tactile hallucination (2 revisions)
  34. Effect:Personality regression (2 revisions)
  35. Problem:Embarrassment (2 revisions)
  36. Adalimumab (2 revisions)
  37. Chlorthalidone (2 revisions)
  38. Effect:Anticholinergic effects (2 revisions)
  39. Problem:Avoidant/Restrictive Food Intake Disorder (2 revisions)
  40. Insulin Degludec (2 revisions)
  41. Effect:Personal bias suppression (2 revisions)
  42. Problem:Alzheimer disease (2 revisions)
  43. Atorvastatin (2 revisions)
  44. Effect:Perception of predeterminism (2 revisions)
  45. Problem:Cardiovascular risk reduction in obesity (2 revisions)
  46. Sucralfate (2 revisions)
  47. Effect:Personal meaning intensification (2 revisions)
  48. Effect:Diarrhea (2 revisions)
  49. Bimatoprost (2 revisions)
  50. Effect:Neuroplasticity (2 revisions)

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://pharmacopedia.wiki/p/Special:FewestRevisions"